| Literature DB >> 32372862 |
Jia-Huan Shang1,2, Wen-Jie Sun1, Hong-Tao Zhu1,3, Dong Wang1,3, Chong-Ren Yang1, Ying-Jun Zhang1,3.
Abstract
BACKGROUND: Root rot is a serious destructive disease of Panax notoginseng, a famous cultivated araliaceous herb called Sanqi or Tianqi in Southwest China.Entities:
Keywords: 20,24-epoxylated; Dammarane-type triterpenes; Hydroperoxylated; Inhibition of NO production; Panax notoginseng
Year: 2019 PMID: 32372862 PMCID: PMC7195571 DOI: 10.1016/j.jgr.2019.01.008
Source DB: PubMed Journal: J Ginseng Res ISSN: 1226-8453 Impact factor: 6.060
Fig. 1Compounds 1–30 from the rot roots of P. notoginseng. (Glc, β-D-glucopyranosyl).
1H NMR (600 MHz, 800 MHz, and 500 MHz in C5D5N) data for compounds 1–7 (δ in ppm, J in hertz)
| No. | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
|---|---|---|---|---|---|---|---|
| 1 | 1.07 m | 1.61 m | 0.96 m | 1.33 m | 1.95 m | 1.82 m | 1.48 m |
| 1.70 m | 1.76 m | 1.44 m | 1.79 m | 3.20 m | 3.11 m | 2.25 m | |
| 2 | 1.88 m, 1.95 m | 2.31 m, 2.84 m | 1.87 m | 1.51 m, 2.46 m | 2.56 m, 3.02 m | 2.40 m, 2.88 m | 2.27 m, 2.77 m |
| 3 | 3.56 dt (11.8,5.1) | 3.51 dt (11.5,4.6) | |||||
| 5 | 1.26 d (10.4) | 1.96 d (10.6) | 1.25 d (10.5) | 1.38 m | 1.69 m | 1.62 m | 1.91 m |
| 6 | 4.44 m | 4.25 m | 4.47 m | 1.42 m, 1.50 m | 1.68 m | 1.62 m | 4.25 m |
| 7 | 1.91 m, 1.99 m | 1.92 m | 1.97 m | 1.28 m, 2.51 m | 1.30 m, 1.48 m | 1.29 m, 1.46 m | 1.86 m |
| 9 | 1.62 m | 1.71 m | 1.91 m | 1.55 m | 2.20 m | 2.13 m | 1.90 m |
| 11 | 1.60 m, 2.17 m | 1.61 m, 2.12 m | 2.37 m, 2.40 m | 1.62 m, 2.07 m | 2.42 m, 2.59 m | 2.40 m, 2.47 m | 1.89 m, 2.24 m |
| 12 | 3.95 m | 3.95 m | 3.93 m | ||||
| 13 | 2.08 t (10.6) | 2.08 m | 3.37 d (9.7) | 2.08 m | 3.24 d (9.0) | 3.23 d (9.4) | 3.27 d (12.0) |
| 15 | 1.04 m, 1.57 m | 1.08 m, 1.63 m | 1.18 m, 1.91 m | 1.08 m, 1.64 m | 1.16 m, 1.79 m | 1.16 m, 1.80 m | 1.13 m, 1.72 m |
| 16 | 1.37 m, 1.86 m | 1.48 m, 1.88 m | 1.90 m, 2.09 m | 1.49 m, 1.91 m | 1.82 m | 1.82 m | 1.71 m, 1.97 m |
| 17 | 2.36 dt (18.0,7.2) | 2.40 dt (18.0,7.2) | 2.74 m | 2.39 dt (18.0,7.2) | 2.78 dd (16.2,7.2) | 2.78 m | 3.37 m |
| 18 | 1.13 s | 1.00 s | 1.32 s | 1.09 s | 1.26 s | 1.24 s | 1.13 s |
| 19 | 1.03 s | 0.88 s | 0.91 s | 0.94 s | 1.19 s | 1.15 s | 0.78 s |
| 21 | 1.42 s | 1.45 s | 1.46 s | 1.47 s | 1.25 s | 1.25 s | 2.22 s |
| 22 | 1.75 td (13.0,4.9) | 2.47 dd (13.8,4.8) | 2.48 dd (13.2,4.8) | 2.49 m | 1.59 m | 1.58 m | |
| 2.28 td (13.1,4.0) | 2.81 m | 2.59 dd (13.5,5.9) | 2.82 dd (13.6,5.5) | 1.95 m | 1.94 m | ||
| 23 | 2.48 m | 6.28 m | 6.16 m | 6.29 m | 1.98 m, 2.05 m | 1.95 m, 2.04 m | |
| 24 | 4.81 t (6.8) | 6.09 d (16.0) | 6.06 d (15.8) | 6.09 d (15.9) | 3.97 t (7.1) | 3.98 t (7.3) | |
| 26 | 5.12 s, 5.29 s | 1.59 s | 1.55 s | 1.60 s | 1.45 s | 1.45 s | |
| 27 | 1.94 s | 1.59 s | 1.55 s | 1.60 s | 1.40 s | 1.40 s | |
| 28 | 2.03 s | 1.70 s | 2.00 s | 1.17 s | 1.50 s | 1.48 s | 1.68 s |
| 29 | 1.48 s | 1.73 s | 1.46 s | 1.08 s | 1.46 s | 1.42 s | 1.64 s |
| 30 | 0.97 s | 1.34 s | 1.02 s | 0.95 s | 0.85 s | 0.85 s | 0.82 s |
| 31 | 3.54 s |
d: doublet; m: multiplet; s: singlet; t: triplet
800 MHz.
500 MHz.
13C NMR (150 MHz, 200 MHz, and 125 MHz in C5D5N) data for compounds 1–7 (δ in ppm)
| No. | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
|---|---|---|---|---|---|---|---|
| 1 | 39.8 | 40.4 | 39.4 | 40.2 | 36.0 | 35.6 | 39.2 |
| 2 | 28.6 | 33.8 | 28.4 | 34.7 | 30.0 | 29.5 | 33.1 |
| 3 | 78.9 | 219.2 | 78.6 | 216.9 | 177.4 | 175.2 | 218.2 |
| 4 | 40.8 | 48.2 | 40.8 | 47.9 | 75.2 | 75.1 | 47.7 |
| 5 | 62.2 | 59.5 | 62.0 | 55.7 | 52.8 | 52.8 | 58.5 |
| 6 | 68.2 | 67.3 | 68.1 | 20.4 | 23.4 | 23.2 | 66.6 |
| 7 | 48.0 | 45.9 | 47.2 | 34.9 | 34.3 | 34.3 | 44.4 |
| 8 | 41.6 | 41.0 | 42.1 | 40.4 | 40.9 | 40.9 | 40.8 |
| 9 | 50.6 | 49.3 | 54.4 | 50.1 | 47.5 | 47.4 | 52.0 |
| 10 | 39.8 | 38.6 | 40.0 | 37.4 | 42.3 | 42.2 | 38.1 |
| 11 | 32.6 | 33.3 | 40.5 | 32.9 | 40.3 | 40.2 | 39.1 |
| 12 | 71.5 | 71.3 | 212.3 | 71.3 | 210.9 | 210.9 | 209.0 |
| 13 | 48.7 | 49.1 | 56.7 | 49.5 | 57.8 | 57.8 | 57.5 |
| 14 | 52.1 | 52.2 | 56.0 | 52.2 | 56.7 | 56.7 | 54.4 |
| 15 | 31.9 | 31.7 | 32.3 | 31.7 | 32.9 | 32.8 | 31.5 |
| 16 | 27.4 | 27.2 | 25.0 | 27.2 | 25.7 | 25.7 | 25.5 |
| 17 | 55.2 | 54.5 | 44.8 | 54.6 | 43.6 | 43.6 | 47.5 |
| 18 | 17.9 | 17.4 | 17.9 | 16.0 | 15.9 | 15.9 | 15.7 |
| 19 | 18.1 | 18.4 | 17.8 | 17.4 | 21.4 | 21.3 | 17.3 |
| 20 | 73.3 | 73.8 | 74.0 | 73.8 | 85.9 | 85.8 | 209.9 |
| 21 | 27.7 | 28.2 | 27.6 | 28.2 | 25.8 | 25.8 | 29.9 |
| 22 | 32.4 | 40.8 | 46.0 | 40.8 | 36.0 | 36.0 | |
| 23 | 26.8 | 127.7 | 127.2 | 127.7 | 27.4 | 27.4 | |
| 24 | 90.6 | 138.1 | 138.7 | 138.1 | 85.1 | 85.1 | |
| 25 | 146.7 | 81.8 | 81.7 | 81.8 | 71.6 | 71.6 | |
| 26 | 113.9 | 25.6 | 25.5 | 25.8 | 27.0 | 27.0 | |
| 27 | 17.8 | 25.8 | 25.7 | 25.6 | 27.6 | 27.5 | |
| 28 | 32.5 | 32.6 | 32.3 | 27.3 | 34.6 | 34.8 | 19.9 |
| 29 | 17.0 | 20.5 | 16.9 | 21.6 | 28.7 | 28.5 | 32.0 |
| 30 | 17.5 | 16.6 | 17.7 | 16.5 | 17.2 | 17.1 | 16.8 |
| 31 | 51.7 |
200 MHz.
125 MHz.
Fig. 2Key 1H-1H COSY, HMBC, and ROESY correlations of Compound 1.
Fig. 3ORTEP of 5 and 7 with thermal ellipsoids shown at 30% probability.
Antiinflammatory activities (uM) of compounds 1, 13, and 14
| Compound | IC50 ± SD |
|---|---|
| 42.47 ± 0.49 | |
| 17.18 ± 0.35 | |
| 25.87 ± 0.60 | |
| L-NMMA | 39.26 ± 0.91 |
SD, standard deviation
Data are expressed as means ± SD (n = 3)
Cytotoxicities (μM) of compounds 9, 12, 13, and 16
| Compound | IC50 ± SD | ||||
|---|---|---|---|---|---|
| Myeloid leukemia HL-60 | Lung cancer A-549 | Hepatocellular carcinoma SMMC7721 | Breast cancer MCF-7 | Colon cancer SW480 | |
| 16.58 ± 0.34 | 34.38 ± 0.42 | 24.16 ± 0.67 | 17.06 ± 0.67 | 17.00 ± 0.37 | |
| 27.37 ± 1.72 | > 100 | > 100 | > 100 | > 100 | |
| 16.13 ± 0.42 | 30.86 ± 0.91 | > 100 | > 100 | 26.79 ± 0.31 | |
| 12.37 ± 0.48 | > 100 | > 100 | > 100 | > 100 | |
| DDP | 2.61 ± 0.07 | 17.80 ± 0.59 | 10.42 ± 0.44 | 19.44 ± 1.56 | 20.80 ± 1.04 |
| Taxol | < 0.008 | < 0.008 | < 0.008 | < 0.008 | < 0.008 |
SD, standard deviation; DDP, cisplatin
Data are expressed as means ± SD (n = 3)